Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Common Chemical Could Lead to Weight Gain in Women

By Kenny Walter | February 13, 2018

A common chemical has been linked to weight gain, particularly among women.

A common grouping of chemicals may be interfering with the body’s natural weight regulation.

Researchers from the Harvard T.H. Chan School of Public Health have found that perfluoroalkyl substances (PFASs) are linked with greater weight gain after dieting, particularly among women. The team also found that higher blood levels of PFASs—known as “obesogens” because they may upset body weight regulations—were linked with lower resting metabolic rate or slower metabolism after weight loss.

“Obesogens have been linked with excess weight gain and obesity in animal models, but human data has been sparse,” senior author Qi Sun, assistant professor in the Department of Nutrition at Harvard Chan School, said in a statement. “Now, for the first time, our findings have revealed a novel pathway through which PFASs might interfere with human body weight regulation and thus contribute to the obesity epidemic.”

PFASs have been used for more than 60 years in various products, including food wrappers, clothing, and pots and pans. Studies have shown that they have contaminated drinking water near industrial sites, military bases and wastewater treatment plants. 

The chemicals have previously been linked to cancer, hormone disruption, immune dysfunction, high cholesterol and obesity.

The research team, which also included scientists from Louisiana State University and Tulane University, analyzed data from 621 overweight and obese participants in the Prevention of Obesity Using Novel Dietary Strategies (POUNDS LOST) clinical trial conducted in the mid-2000s. The trial tested the effects of four heart-healthy diets on weight loss over a two-year period.

The researchers looked at the possible connection between the amount of PFASs in participants’ blood as they entered the study and their weight loss or gain over time. They found that during the first six months the participants lost an average of 14.1 pounds, but regained almost 6 pounds over the next 18 months.

Those who gained the most weight back also had the highest blood concentrations of PFASs, and the link was strongest among women. The women who had the highest PFAS blood levels regained on average 3.7-to-4.8 pounds more body weight than women in the lowest third.

They also found that higher blood concentrations of PFASs were significantly associated with lower resting metabolic rates.

“We typically think about PFASs in terms of rare health problems like cancer, but it appears they are also playing a role in obesity, a major health problem facing millions around the globe,” study co-author Philippe Grandjean, an adjunct professor of environmental health at Harvard Chan School, said in a statement. “The findings suggest that avoiding or reducing PFAS exposure may help people maintain a stable body weight after they successfully lose some weight, especially for women.”

The study was published in PLOS Medicine. 

Related Articles Read More >

OpenAI research and product leads detail GPT-Rosalind capabilities and benchmarks
Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents
Mammogen raises up to $30M to advance RNA blood test for early breast cancer detection
injecting injection vaccine vaccination medicine flu man doctor insulin health drug influenza concept - stock image
Lilly’s $3.8B vaccine deal caps a $25B, 2026 push to preempt disease
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE